ERS International Congress, Paris 2018

Browse by day: Saturday, 15.09.2018 Sunday, 16.09.2018 Monday, 17.09.2018 Tuesday, 18.09.2018 Wednesday, 19.09.2018		View the presentations you missed during Congress! More than 1,700 webcasts and slide presentations, 1,600 e-posters and 4,200 abstracts from the International Congress in Paris and are now available.

Citations should be made in the following way: Authors. Title. Eur Respir J 2018; 52: Suppl. 62, abstract number.

New biologics for asthma: which patients, which agents, which results, at what cost?

Lunchtime session
Chairs: J. Drazen (Boston, United States of America), K. Rabe (Grosshansdorf, Germany)
Aims: Multiple biological agents have recently become available for treating asthma and are being heavily promoted by industry. The translational scientist views them as biologically informative tools, while the clinician views them as new ways to help difficult-to-treat patients. These different views lead to important questions that this session seeks to answer. They include, but are not limited to, How do these agents exert their effects? What do we really know about these treatments and how should they be used in clinical practice? How are the available agents similar and different? Which side effects should be closely monitored? Do these treatments modify the “natural course” of asthma? Are these treatments worth their cost?

Download all media

The basic science behind asthma biologics S. Wenzel (Pittsburgh, United States of America)
At the interface: the translational science supporting the clinical use of anti-cytokine therapy E. Bel (Amsterdam, Netherlands)